ERYtech Pharma announces the results of its phase II clinical trial
KEY POINTS
Lyon, a leading city in life sciences
BIOPARC LYON, fully dedicated to biotech companies
A 3.4 ha site
40,000 square meters hosting offices and laboratories, a business incubator, technical rooms, a residential complex, support services...
PRESS RELEASE
ERYtech Pharma announces the results of its phase II clinical trial
Lyon (France), Philadelphia (USA), 10 December 2008,
ERYtech Pharma, the specialty pharmaceuticals company developing red cell-based
medicinal products, announces the results of its phase II clinical trial.
GRASPALL 2005-1 was presented orally on the 8th December 2008 at the 50th Annual
Meeting of the American Society of Hematology in San Francisco (USA).
GRASPALL 2005-1 was presented orally on the 8th December 2008 at the 50th Annual
Meeting of the American Society of Hematology in San Francisco (USA).
